news M6A modification is crucial for HIV-1 survival 12 April 2024 | By Drug Target Review The discovery of three m6A modifications and their exact locations could lead to the development of drugs that inhibit viral RNA and protein production.
news A mathematical algorithm to network complex drug interactions 21 June 2022 | By Ria Kakkad (Drug Target Review) Researchers used mice to develop a mathematical algorithm of a heart attack.
news Novel AI tool takes a DeepCE dive into potential drugs for COVID-19 2 February 2021 | By Hannah Balfour (Drug Target Review) A new phenotype-based compound screening technology, called DeepCE, identified 10 compounds that could be repurposed for COVID-19.
news Using CRISPR to develop a cutaneous leishmaniasis vaccine 30 September 2020 | By Hannah Balfour (Drug Target Review) Researchers used CRISPR gene-editing to develop a vaccine able to protect against the spread of the Leishmania major parasite which causes cutaneous leishmaniasis.
news Scientists develop a new way to fight late-stage sepsis 7 January 2020 | By Drug Target Review Scientists have used nanotechnology to transform healthy immune cells into a drug with enhanced power to kill bacteria to help the immune system fight sepsis.